Options trading is a way for people to bet on whether a stock will go up or down in price. Some rich people or big companies have been betting that Amgen's stock will go down in the next three months. They are using options to do this. We looked at the options and saw that they are mostly betting that the stock will be between $300 and $325 in the next three months. This means they think Amgen's stock will not change much in price during that time. Read from source...

- Critics the story for not providing enough context about the options trading, which could be seen as a bearish sign
- Highlights the inconsistency in the data, such as the volume and open interest not matching, and the large difference in the amounts and number of trades
- Questions the credibility of the data, as it could be manipulated or inaccurate
- Points out that the bearish sentiment is not supported by the options pricing, which shows that the trades are not fully hedged
- Suggests that the article is written to create fear and uncertainty among retail traders, rather than to inform them
- Argues that the article is not helpful for investors, as it does not provide any actionable insights or recommendations

Bearish
Article's Key Points:
1. Whale investors with a lot of money have taken a bearish stance on Amgen.
2. We noticed this today when the trades showed up on publicly available options history.
3. The overall sentiment of these big-money traders is split between 16% bullish and 75%, bearish.
4. Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $300.0 to $325.0 for Amgen over the recent three months.
5. Benzinga Pro gives real-time options trades alerts for Amgen.

AI is the only AI that provides comprehensive investment recommendations and risks based on market data, news, and user preferences. It considers options, earnings, analyst ratings, dividends, IPOs, and more to create a diverse set of actionable ideas for investors.